Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Bone Care International and Cardinal Health in Hectorol copromotion

July 19, 2004

Scientists at Lilly describe vitamin D receptor modulators

July 16, 2004

BLX-1002 improves metabolic syndrome-type abnormalities in fructose-fed rats

July 16, 2004

Vanillin prodrug may be effective for patients with sickle cell disease

July 16, 2004

Indolyl derivatives claimed by Roche

July 15, 2004

Cellegy and Strakan enter European commercialization agreement for Tostrex

July 15, 2004

Potent glycogen synthase kinase-3beta inhibitors effective in vivo

July 15, 2004

Fluorinated amides disclosed by Pfizer

July 14, 2004

McNeil and ICAgen enter agreement for ICA-17043 for sickle cell anemia

July 14, 2004

New Glimicron presentation launched in Japan

July 14, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...